company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3606314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3606314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1072855000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,782031000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,786008000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1063365000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5183843000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5183843000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1656207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32852000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,586267000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33485000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1136277000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1136277000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4044493000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1058793000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1959150000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1249804000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2312632000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2312632000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,200258000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 16:05:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1935192000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4880719000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,146503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4734216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1051728000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,787101000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,461261000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-39686000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6994620000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6994620000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1287724000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-250000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-923937000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,449231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-75061000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2087491000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2087491000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1238687000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1081806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2174252000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1008843000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3485902000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3485902000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-115160000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,349571000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 15:03:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1655638000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1536226000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,146503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1389723000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,220884000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,201671000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,172062000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-751757000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1232583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1232583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-264592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-168487000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,130586000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-49692000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-352185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-352185000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,541281000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8679000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-558509000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47875000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47875000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,23835000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,349571000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q4,2008-10-01,2008-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1301679000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3344493000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3344493000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,830844000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,585430000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,289199000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,712071000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5762037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5762037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1023132000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-250000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-755450000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,318645000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-25369000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1735306000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1735306000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1779968000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1073127000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1615743000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,935061000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3533777000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3533777000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-138995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3YTD,2008-01-01,2008-09-30,2009-11-06 10:45:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,353959000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1084612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1084612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,296218000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,202342000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,66806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1048433000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2698411000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2698411000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-319805000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-250000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,453753000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,61953000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1579968000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1692000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-555557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1699869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,471892000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3365194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3365194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-265361000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q3,2008-07-01,2008-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-986243000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2259881000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2259881000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,534626000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,383088000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,222393000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-336362000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3063626000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3063626000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-703327000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1209203000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,318645000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-87322000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1681207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1681207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1071435000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1060186000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1699869000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,463169000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-168583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-168583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,126366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2008.0,Q2YTD,2008-01-01,2008-06-30,2009-08-07 09:27:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1340202000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5745838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5745838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1210977000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,878533000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,578324000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1138512000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7275160000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7275160000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1089048000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2370630000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248970000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16306000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3698710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3698710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2483176000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-826345000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2414460000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6217331000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,508669000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1002019000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1002019000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,118848000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,FY,2009-01-01,2009-12-31,2011-02-18 15:03:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4697317000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1538729000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1538729000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324613000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,222740000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,270826000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-524291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1832617000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1832617000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-245447000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-851727000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,2646721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16306000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2976000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1562877000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1562877000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-959000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-618776000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,936258000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,186850000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,503373000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,503373000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3933424000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4207109000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4207109000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,886364000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,655793000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,307498000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-614221000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5442543000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5442543000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-843601000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1518903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2895691000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3392000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5261587000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5261587000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2483176000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-825386000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1795684000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5281073000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,321819000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,498646000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,498646000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,84291000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-05 13:50:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,763893000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5743335000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,146503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5596832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1107248000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,857464000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,479560000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1365978000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6675126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6675126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1108193000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1518903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3064178000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,130586000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-53084000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5613772000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5613772000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1941895000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-834065000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2354193000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5281073000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,395601000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,546521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,546521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,108126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,349571000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3TTM,2008-10-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2065572000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1480367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1480367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,312225000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,228489000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,62587000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,946356000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3030024000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3030024000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-328710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9512000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1177958000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2257000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1518437000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1518437000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-605000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-618376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-266352000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-856333000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-856333000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16357000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,671611000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2726742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2726742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,574139000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,427304000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,244911000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1560577000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2412519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2412519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-514891000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1509391000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1717733000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1135000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3743150000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3743150000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2483176000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-824781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1177308000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5547425000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,292819000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1354979000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1354979000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,67934000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-05 13:33:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,92282000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5347580000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,146503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5201077000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1091241000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,831317000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,483779000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1263901000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6343513000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6343513000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1099288000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1759391000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1432467000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,130586000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,11126000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4149434000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4149434000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3521863000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-835152000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2291374000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3847556000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,838493000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1962340000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1962340000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-173592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,349571000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2TTM,2008-07-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,407718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1288105000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1288105000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,304067000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,233331000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,57964000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-169666000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1713801000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1713801000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262740000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17332000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1717733000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-138962000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-625000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2137392000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2137392000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1828000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-618227000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,777007000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13425000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-329623000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-329623000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,82723000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q2,2009-04-01,2009-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-670491000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1438637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1438637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270072000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,193973000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,186947000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1390911000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,698718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,698718000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-252151000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1492059000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,138962000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-510000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1605758000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1605758000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1983176000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-822953000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-559081000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4770418000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,279394000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1684602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1684602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14789000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2009.0,Q1,2009-01-01,2009-03-31,2010-06-09 11:09:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,762773000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4626172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4626172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1207450000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1416855000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,826720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,658784000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-516363000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-516363000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1015075000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9433243000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-805932000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,954361000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1888426000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12188315000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12188315000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1877852000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-866825000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2671475000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,328411000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1087741000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1087741000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-620893000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,8735981000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5677331000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,580168000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,FY,2010-01-01,2010-12-31,2012-02-21 15:11:18+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,809710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1440847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7811497000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,303231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,406347000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,496484000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-330390000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6935825000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6935825000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-291333000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-313200000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-805932000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1019336000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10588000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2440389000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2440389000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-456927000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-652000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-692101000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-93314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-93314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,47410000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,8735981000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-686137000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,580168000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,809710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3185325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3185325000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,904219000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1010508000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,330236000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,989174000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6419462000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6419462000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-723742000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9120043000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1973697000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1877838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9747926000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9747926000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1420925000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-866173000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1979374000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,272045000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-994427000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-994427000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-668303000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-04 14:00:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4991194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4724054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4724054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1228832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1233248000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,601062000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,464883000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8252079000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8252079000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-969189000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9971770000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,2646721000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1990003000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1880814000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8185049000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8185049000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1420925000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-867132000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2598150000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3936258000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,458895000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-491054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-491054000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-633746000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1057770000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,890660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,890660000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,313158000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,363866000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,72146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,908583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2548413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2548413000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-205085000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14317000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2230000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2392998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2392998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-73814000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2326000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-679423000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,68457000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-687106000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-687106000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,28134000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-503557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2294665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2294665000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,591061000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,646642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,258090000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80591000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3871049000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3871049000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-518657000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6920043000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1959380000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1875608000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7354928000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7354928000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1347111000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-863847000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1299951000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,203588000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-307321000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-307321000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-696437000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-04 15:04:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4487637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5313761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5313761000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1227899000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1097871000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,591503000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,502656000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8733690000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8733690000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1092814000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7781282000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1468763000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1975686000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1880841000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7310488000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7310488000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1347111000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-865411000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2537103000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3669906000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,419438000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-660281000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-660281000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-645523000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,117398000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1291650000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1291650000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,303812000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,371390000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,84224000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,297221000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2348297000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2348297000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-273514000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-504395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1085241000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,303832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,303832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1345857000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2479000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-679199000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2224994000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15419000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,212878000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,212878000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-110125000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2754882000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1003015000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1003015000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287249000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,275252000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,173866000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-216630000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1522752000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1522752000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-245143000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6415648000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,874139000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1872108000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7658760000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7658760000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1254000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-861368000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-620752000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,775006000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,188169000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-520199000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-520199000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-586312000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:14:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7242519000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5310216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5310216000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1228154000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,959812000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,565243000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35769000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8099194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8099194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1082040000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7294219000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-248970000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,751483000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1877966000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9751712000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9751712000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-501254000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-864760000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2476131000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2221919000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,417444000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1202782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1202782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-452675000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3307975000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4728449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1395371000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1648523000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1196667000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1067000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8970077000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8970077000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1491500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-672500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5109987000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5648720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1886099000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,260832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,260832000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4977111000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77007000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2938096000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,968759000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6023455000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6023455000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-43005000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3164449000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,544559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,FY,2011-01-01,2011-12-31,2013-02-15 15:15:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1781602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1618668000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1618668000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,241173000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,407256000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,604064000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1469812000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1401349000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1401349000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-274735000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4016439000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5648720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6928000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1364474000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1364474000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2181445000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2579000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-752090000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,651296000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1284818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1284818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,282516000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1763521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,544559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1781602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3109781000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1154198000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1241267000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,592603000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1470879000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7568728000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7568728000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1216765000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-672500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1093548000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1879171000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1103642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1103642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2795666000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-74428000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2186006000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,317463000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4738637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4738637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-325521000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1400928000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-07 14:04:37+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4550628000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4701716000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1457429000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1647614000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1089087000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1140489000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,632903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,632903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1508098000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-985700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1899480000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1019336000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1868583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3544031000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3544031000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3252593000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-75080000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2878107000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,373829000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4831951000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4831951000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-278111000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,8735981000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,714791000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,580168000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,809710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,303181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,303181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,420712000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,417674000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,67838000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1845025000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3054430000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3054430000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-451995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1932189000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3199000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,991995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,991995000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-788987000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-583000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-751630000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1174730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47808000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2668122000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2668122000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-406022000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,972281000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2806600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2806600000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,733486000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,823593000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,524765000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-374146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4514298000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4514298000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-764770000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-187500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3025737000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1882370000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2095637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2095637000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2006679000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-73845000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1434376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1174730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,269655000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2070515000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2070515000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,80501000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,428647000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-07 14:37:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5138107000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4114237000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1349875000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1593806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1093395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,204047000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,126886000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,126886000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1261188000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2700700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3831669000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1005019000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1869552000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6929024000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6929024000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2537420000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-76823000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2805900000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2174730000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,394478000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2850935000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2850935000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,156045000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,8735981000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-761047000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,580168000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,809710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1942782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1942782000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,379366000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,432046000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,248957000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-499999000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2503152000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2503152000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-372957000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-187500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1108516000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1874566000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,205593000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,205593000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1506097000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2095000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-750409000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,778517000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,93903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1386181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1386181000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14298000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1336862000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,863818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,863818000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354120000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,391547000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,275808000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,125853000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2011146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2011146000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-391813000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1917221000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7804000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2301230000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2301230000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500582000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-71750000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-683967000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,396213000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,175752000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-684334000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-684334000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,66203000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-908215000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 15:38:12+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4486975000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4765369000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1274321000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1533150000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,928662000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1001267000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27969000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27969000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1161745000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3017595000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2723153000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,80222000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8514000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6830785000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6830785000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2377180000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2734690000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3621207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,315994000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1251876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1251876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,31622000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,8735981000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,656973000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,580168000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,809710000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5963000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5963000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1363000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1419000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2428000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1859000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9314000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9314000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1795000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-706000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11998000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5560000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5560000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11071000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2364000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15484000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3989000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,FY,2012-01-01,2012-12-31,2015-02-27 12:57:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1053461000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1053461000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,257559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,330011000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1809265000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1947557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1502739000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1502739000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-385807000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-24376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9751817000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1002000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1224998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1224998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11017000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-640652000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-812063000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14695642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,279438000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2505365000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2505365000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21766000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2804872000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4909539000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4909539000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1105441000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1088989000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,618735000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,88557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7811261000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7811261000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1409193000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-681624000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2246183000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4335002000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4335002000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1723348000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2370937000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,788358000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1049562000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2310365000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2310365000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18234000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1184128000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 16:05:51+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6528207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6528207000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1346614000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1496245000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1222799000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1381255000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9212610000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9212610000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1683928000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-681624000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6262622000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5648720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,8926000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2970528000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2970528000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2235445000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1725927000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3123027000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1788358000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1700858000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3595183000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3595183000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,300750000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2947649000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,544559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1781602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1942803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1942803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,430344000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,329384000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,75608000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,741363000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3519502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3519502000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-530747000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21624000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,431074000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10310000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-131607000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-131607000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1234000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-805405000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1908411000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,124093000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2590957000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2590957000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,147234000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,944172000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2966736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2966736000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,675097000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,759605000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,543127000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-652806000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4291759000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4291759000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-878446000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-660000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2677257000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12308000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4203395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4203395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1722114000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1565532000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2696769000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,925469000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,280592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,280592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-129000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,239956000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 12:33:40+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4888585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4888585000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1336982000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1584535000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1215029000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-277593000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8747538000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8747538000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1605176000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4761507000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5648720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,16037000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1846926000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1846926000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3024432000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1725276000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3069252000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2522039000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1624573000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3672348000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3672348000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-252506000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2975758000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,544559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1781602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1724612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1724612000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,320886000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,370549000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,195785000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-545003000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2066829000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2066829000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-425116000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1222327000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1159000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,688370000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,688370000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-734428000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-806984000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1297740000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,359039000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,115367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,115367000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-163700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2706866000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1242124000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1242124000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,354211000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,389056000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,347342000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-107803000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2224930000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2224930000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-453330000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3899584000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,11149000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4891765000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4891765000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-987686000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-758548000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1399029000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,566430000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165225000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165225000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,34700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2466910000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 15:33:31+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5106755000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5106755000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1395462000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1646032000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1268201000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-232589000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9183861000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9183861000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1553017000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1222500000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7092350000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5648720000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1889444000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2329703000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2329703000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4530529000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-992943000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3012677000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2002816000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1359437000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5173896000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5173896000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-74508000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1605754000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,544559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1781602000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,928000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,791000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,266000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1237000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3324000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3324000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10064000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7839000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3929000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3929000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1605000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-882000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2095000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6001000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6696000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6696000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-26000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7327000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,FY,2013-01-01,2013-12-31,2015-02-27 12:57:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1039000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,228000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1625000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1625000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-14000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6684000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7839000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,840000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,840000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-39000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-218000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1429000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,120000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1869000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1869000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,593000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1039000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3040461000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3040461000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,957559000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,923011000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2031265000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3750557000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3201739000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3201739000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1227807000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-590376000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13131817000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,20002000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5993998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5993998000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11017000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2206652000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1476063000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18219642000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5841562000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2321635000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2321635000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1234000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5115128000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,239000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,45000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-925000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-277000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1873000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2697000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2697000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-351000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-220000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,374000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-362000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-559000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-559000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,44000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2690000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1987000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1987000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,700000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,593000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,222000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1803000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1699000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1699000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-842000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3380000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4769000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4769000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-664000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3524000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6121000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4827000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4827000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-23000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-06 17:01:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7920000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4017264000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4017264000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1148903000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1055395000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2061873000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2084194000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6199241000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6199241000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1481554000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-46000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10827743000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9308000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3428605000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3428605000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11017000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1856886000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2061468000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15937231000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5355469000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4353592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4353592000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,102000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1480956000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,239000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,717000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,717000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-291000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,327000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-290000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-220000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,902000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,465000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,465000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1021000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1021000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,461000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,177000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-878000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1177000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1177000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-565000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1507000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2072000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2072000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1215000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-444000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5759000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4268000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4268000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-67000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 16:32:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5230000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,222000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,126000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,460000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,460000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-274000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1834000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-925000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2248000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5832000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6429000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 16:47:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,5264876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5264876000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1230789000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1228944000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2206658000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2382197000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7549070000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7549070000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1615670000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9932416000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8149000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2776235000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2776235000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11017000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2301314000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2648452000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,16332971000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5069430000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4703225000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4703225000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-42700000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26910000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,576000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2284000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2284000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,630000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-490000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3675000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3675000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1077000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3317000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1507000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5624000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-202000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-202000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-577000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1342000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1343000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2742000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2742000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,588000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 16:17:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,229000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,125000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-186000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-287000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-495000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1507000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2266000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,8000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-577000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,74000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-700000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-700000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-78000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,450000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1380000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1380000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,689000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,464000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,208000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-304000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2437000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2437000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-790000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3358000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,62000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-192000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-192000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2194000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1007000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1269000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2042000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2042000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-65000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-05 14:37:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,138000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,662000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,252000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,262000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1093000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2836000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6684000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,64000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,648000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,648000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2233000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1225000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3911000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3911000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-68000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,731000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1039000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,539000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,539000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,129000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,267000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-277000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2239000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-331000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,397000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-336000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-271000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-271000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-62000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,841000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,841000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,463000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,168000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-571000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1236000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1236000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-513000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1119000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,633000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,633000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2193000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-676000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,872000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1771000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1771000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 16:28:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,95000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,730000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,257000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3383000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3383000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1093000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8557000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8958000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2583000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1114000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,38000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2002000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1039000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,239000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,161000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,900000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,900000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-258000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1119000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1228000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1228000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-333000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-341000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-619000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-619000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1510000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,375000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,174000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,119000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-556000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,336000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,336000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-367000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-595000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-595000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2192000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-343000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1213000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1152000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1152000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:56:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1415000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,766000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,259000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1162000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1126000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8597000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7839000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2416000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2416000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-303000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2872000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1001000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1060000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3115000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3115000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2313000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1039000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4423000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4423000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,871000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,601000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2773000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2966000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1110000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-235000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4933000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,230000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,52000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,406000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,406000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1338000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2237000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1443000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,297000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2236000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2236000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-198000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,938000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:04:37+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,767000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,223000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,143000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-327000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-248000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2307000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-2290000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,9000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1566000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,717000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-888000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-360000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-497000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-497000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1869000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3656000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,648000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,458000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2795000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2138000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2138000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-862000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-235000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2626000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2055000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1083000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,263000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1739000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1739000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-03 16:26:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-931000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4560000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4560000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,877000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,624000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2670000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3376000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3376000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1149000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-730000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2525000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2266000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,51000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2632000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1350000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2559000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2439000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2439000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-248000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-481000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,580000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,205000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-411000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-231000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-504000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-359000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,50000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-99000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-916000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3076000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,416000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,307000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-34000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,943000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,943000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-451000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2056000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1551000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1347000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-724000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,213000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-924000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-924000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-71000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-03 16:32:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,871000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2657000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,47000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3382000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3382000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1015000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3321000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2525000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4505000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,71000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2128000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1390000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2956000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-211000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,478000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-149000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-46000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,941000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,941000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-216000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1843000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2290000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,242000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-360000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-374000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-374000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,215000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2673000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-235000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-213000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,230000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-205000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-205000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1481000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1346000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-364000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-84000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:32:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-837000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4201000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,909000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,612000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2459000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,78000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3341000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3341000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1057000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3317000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1353000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,235000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5624000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,56000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2058000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1349000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1363000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-223000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,448000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1400000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1400000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,803000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1513000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3203000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3203000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1121000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-80000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2823000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3709000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,42000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-248000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-248000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1949000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1539000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,223000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11147000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11147000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13619000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,FY,2016-01-01,2016-12-31,2019-02-22 16:13:21+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,198000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,286000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,132000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1841000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3709000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,8000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1086000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13504000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13504000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16120000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,602000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,605000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,429000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1666000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1269000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2033000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2033000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-802000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-982000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,34000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1798000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-863000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-522000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1153000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2357000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2357000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-02 16:18:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2501000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1369000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,572000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1688000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1596000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2861000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2861000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1050000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-2265000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-232000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-232000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-146000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1410000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1513000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,215000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2854000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2854000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-407000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-632000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1000000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,206000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-312000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-66000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-182000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-554000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-554000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-436000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,76000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-746000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-746000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-78000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,931000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,931000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,666000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1475000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,816000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,816000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-490000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-800000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-427000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-520000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-769000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,105000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1611000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1611000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-02 16:16:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2423000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2278000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2278000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,860000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,583000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1597000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2839000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2839000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1149000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3677000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-2265000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6402000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,52000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-875000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-875000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-214000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1410000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1488000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,189000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2923000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2923000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-511000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1470000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,202000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,62000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-115000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,909000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,909000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-800000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-446000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,30000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1470000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1470000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,163000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-179000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-179000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-16000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-756000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,316000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,316000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,203000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,144000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,604000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1360000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-93000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-93000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-243000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,446000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-590000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-385000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:17:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1667000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,859000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,504000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1528000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2871000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2871000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1118000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-235000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4720000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6848000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,837000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,837000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1410000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1464000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,203000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3118000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3118000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-482000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,166000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,477000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1046000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2887000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-755000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1915000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1135000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-17183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-210000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,6042000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2833000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9618000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9618000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9684000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-117000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1849000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6742000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5281000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5281000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 16:28:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-828000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,283000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,632000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1640000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1640000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-345000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4156000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-112000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,600000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,856000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3152000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3152000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5744000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-11000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-464000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6742000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,75000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-112000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-112000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-97000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1721000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1305000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1305000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,763000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-790000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13027000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5442000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1977000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,30000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3940000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-106000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1385000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,262000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5169000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5169000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,97000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-31 16:02:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7608000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,961000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2541000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-693000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1109000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13034000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1939000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5442000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5686000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,38000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4916000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4916000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5026000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-106000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1771000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,304000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,379000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8512000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,603000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,603000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,519000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,63000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,565000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2005000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2005000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-263000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-29000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-306000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-306000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-463000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-386000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,508000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1736000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-888000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1925000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1925000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-527000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13027000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5471000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1924000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-98000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-922000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,173000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4783000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4783000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-01 16:02:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8945000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,906000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2162000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4312000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4312000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1158000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2051000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5471000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5633000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,41000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5164000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5164000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5458000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1692000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,291000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7975000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7975000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-410000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7097000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,283000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,283000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,92000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-102000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1351000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1351000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-255000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,239000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-462000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,57000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-384000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-65000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,419000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,419000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,252000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,914000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-980000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,574000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-272000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13027000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5472000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1685000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6154000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6154000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-95000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-460000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,116000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4399000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4399000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,65000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:17:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9914000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1503000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1503000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,852000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,214000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-184000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3870000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3870000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2838000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5472000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4948000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,47000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6628000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6628000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-98000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1614000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14934000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,277000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8180000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8180000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,433000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5372000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,620000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2368000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1100000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2210000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,770000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6300000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6300000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1394000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-54000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-131000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,102000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1356000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1356000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12459000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1974000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4009000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,271000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10391000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10391000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5447000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 16:28:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,654000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,654000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,275000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,488000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,374000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1765000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-467000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,17000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4180000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-495000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-24000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4776000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4776000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,98000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3409000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1714000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,825000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1722000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-122000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4535000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4535000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-927000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,85000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-860000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-860000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8279000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1479000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4033000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5615000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-98000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-31 16:02:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2038000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,886000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,886000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2354000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,466000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1361000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6175000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6175000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1272000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-135000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,648000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,856000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,90000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4012000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4012000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14023000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-145000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1943000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10775000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,319000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5727000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5727000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-195000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3759000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,563000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,269000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,544000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,83000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,724000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2183000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-354000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-323000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-323000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-999000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-494000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3893000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,74000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2471000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2471000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4304000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1151000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,556000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1178000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,313000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-846000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2352000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-573000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-537000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-537000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7280000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-131000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-985000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8086000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8086000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-71000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-31 16:15:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6342000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,926000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1094000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2329000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,446000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1202000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5997000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5997000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4199000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-224000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,619000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,909000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3995000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3995000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13028000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1912000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6882000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,334000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8584000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8584000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-144000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6726000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,733000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,288000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,562000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,101000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-440000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-298000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-299000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-299000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1301000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-494000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,134000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,33000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1631000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-106000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-792000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,418000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,268000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,616000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,212000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-406000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1108000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-275000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,67000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-238000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5979000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-128000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-491000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,137000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6455000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6455000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:09:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5550000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,476000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1062000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2589000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,437000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1540000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1138000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4181000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-200000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1148000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,99000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11703000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-710000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-150000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1880000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6748000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,358000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7337000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-65000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,35000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4965000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,917000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,570000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1049000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1049000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,273000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,332000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,279000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2416000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2416000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-434000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-489000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-489000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2918000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-496000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-568000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1790000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2185000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2185000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-215000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,677000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3687000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1078000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1936000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,766000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1331000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6136000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6136000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-170000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1815000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3441000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-718000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2270000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1842000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,298000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4289000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,677000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 16:28:23+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3292000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1080000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1941000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,808000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1636000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5485000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1671000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-182000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-130000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4703000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-326000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2197000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,28000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,318000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6880000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6880000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,55000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3162000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,960000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,484000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,94000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,140000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1948000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1948000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-401000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-11000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-432000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-569000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-513000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-513000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-49000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,954000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,805000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1453000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,434000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1610000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3720000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3720000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1204000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,23000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1326000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1326000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-523000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-222000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1702000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,52000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,291000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2104000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-43000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-31 16:02:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,247000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2895000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1079000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2001000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,797000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1052000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5720000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5720000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1624000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-171000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1713000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1713000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5700000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-328000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2122000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3909000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,345000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3896000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3896000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,77000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,188000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1006000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1006000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,268000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,483000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,114000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-811000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1060000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1060000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-468000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-82000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-498000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-498000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-568000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,27000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,117000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-449000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-449000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1678000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1678000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,535000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,969000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,340000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1750000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1772000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1772000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-803000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-160000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-894000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-894000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-521000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-221000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-1133000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,40000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1591000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1591000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,6000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-31 16:15:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-707000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,672000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,267000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,486000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,226000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-939000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,712000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,712000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-335000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-78000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-396000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-217000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-565000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,127000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1142000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1142000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,4000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-29 16:16:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-822000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2622000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2622000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1099000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2080000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,784000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-681000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5904000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1454000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-126000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,50000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1514000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1514000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6980000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-327000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2048000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4016000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,261000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5078000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5078000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-31000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-719000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,845000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,740000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3579000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3579000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1078000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2011000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,773000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1302000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1663000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-92000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-139000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,48000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,15000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1812000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1812000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2942000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-737000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2343000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1880000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,260000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3882000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3882000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-74000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,371000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,677000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,930000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,564000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,564000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,267000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,561000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,233000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-910000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,715000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-360000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-393000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-393000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-236000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-638000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,51000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,89000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-735000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-735000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-70000000.0
Abbott Laboratories,ABT,HQD377W2YR662HK5JX27,0000001800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-29 16:16:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-483000000.0
